Search for: "WYETH PHARMACEUTICALS INC"
Results 321 - 340
of 515
Sorted by Relevance
|
Sort by Date
29 Dec 2010, 12:54 pm
Wyeth, Inc. v. [read post]
2 Feb 2010, 7:28 am
The other side first argued, after Wyeth v. [read post]
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
24 Jun 2013, 12:50 pm
Wyeth, 619 F.3d 632 (6th Cir. 2010), is no longer good law for the proposition that earned it that ranking. [read post]
19 Feb 2016, 11:57 am
Isonas, Inc., 2014 WL 10988340 (C.D. [read post]
29 May 2014, 5:00 am
Wyeth-Ayerst Laboratories, 1994 WL 532091, at *1 (E.D. [read post]
1 Apr 2024, 6:18 am
Wyeth Pharmaceuticals, Inc., 616 F.3d 134 (2d Cir. 2010), that a plaintiff is not required to prove the employer's articulated reason is false, and that the the plaintiff can prevail by showing that an unlawful factor (like sex, race, etc.) was a motivating factor, even "without proving that the employer's proffered explanation was not some part of the employer's motivation. [read post]
18 Jan 2016, 5:00 am
Pfizer, Inc., ___ F. [read post]
30 Apr 2013, 12:14 pm
Merrell-Dow Pharmaceuticals, Inc., 523 A.2d 374 (Pa. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
5 Nov 2014, 4:00 am
Allegan, Inc., 2014 U.S. [read post]
12 Feb 2015, 12:56 pm
Wyeth Laboratories, Inc., 734 A.2d 1245 (N.J. 1999) – the decision that makes New Jersey the only state to adopt a direct-to-consumer (“DTC”) exception to the learned intermediary rule (putting aside West Virginia’s use of DTC as an excuse for rejecting the rule altogether). [read post]
8 Oct 2008, 11:50 am
Wyeth, Inc., 508 F. [read post]
21 Jun 2012, 4:30 am
Wyeth Labs., 498 F.2d 1264, 1276 (5th Cir. 1974). [read post]
24 Dec 2014, 5:00 am
Wyeth, Inc. v. [read post]
18 Apr 2007, 10:06 pm
Merrell Dow Pharmaceuticals, Inc., 569 N.E.2d 875, 878-79 (Ohio 1991). [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
